You are here
- Home
- Therapy Areas
- Gastrointestinal
What is the value of the use of validated questionnaire (Reflux Impact Scale) for predicting treatment success with PPI.
- Disease
- acid reflux
- Drug Name
- Nexium
- Generic Name
- esomeprazole
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IV
- Start Date
- Oct 1, 2007
- Study Name
- NL401611
- Study Id
- NL401611
- ClinicalTrials.gov ID
- NCT00536328
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
